Philadelphia Researchers Working On COVID-19 Vaccine Currently Being Tested On 20 People

Stephanie Stahl reports.

COMMUNITIES AND TOUR A HONEYWELL FACILITY MAKING N95 MASK.FIRST AT 4:00 PHILADELPHIARESEARCHERS ARE WORKING ON ACOVID-19 VACCINE THAT ISCURRENTLY BEING TESTED ON 20PEOPLE HERE.IT IS USING NEW UNPROVENGENETIC TECHNOLOGY THAT COULDBE FASTER THEN TRADITIONALVACCINE DEVELOPMENT.HEALTH REPORTER STEPHANIESTAHL SPOKE WITH ONE OF THEFIRST VACCINE VOLUNTEERS INPHILADELPHIA AND SHE BEGINSOUR COVERAGE TODAY, HI THERESTEPHANIE.REPORTER: THINKS ONE OF ADOZEN VACCINE IN THE VERYEARLY STAGES OF TESTING.REASON IS THERE SO MUCHINTEREST AND EXCITEMENT ABOUTTHE ONE BEING TESTED HERE INPHILADELPHIA IS IT IS THEABILITY TO POTENTIALLY BE FASTTRACK AND FOR VOLUNTEERS INTHIS FIRST PHASE OF TESTINGTHERE APPEARS TO BE LITTLERISK.HELPING TO RESPOND TO THISPANDEMIC, IT IS LIKE AWONDERFUL OPPORTUNITY.REPORTER: ANTHONY CAMPIS-I1OF THE 20 VOLUNTEERS TESTINGCOVID-19 VACCINE AT THEUNIVERSITY OF PENNSYLVANIA.I FEEL IT IS UNCOUPLE BENTUPON EVERYONE TO DO EVERYTHINGTHEY CAN IN A MOMENT LIKETHIS.REPORTER: TRADITIONALVACCINES TAKE YEARS AND THISONE FROM A FARM SUIT CALLSCOMPANY IN PLYMOUTH MEETINGUSING A DNA REPUBLICAN MAKE ONOF THE CORONAVIRUS GENE NOMERELEASED BY CHINA DEVELOPMENTCOULD BE MUCH FASTER ACCORD TOGO DOCTOR KIM AHEAD OF THEPHARMACEUTICAL COMPANY.ABOUT 1 MILLION DOSES, THATIS BEFORE THE END OF THE YEAR.REPORTER: THINKS PHASE ONEOF THE CLINICAL TRIAL WHEREVACCINE'S SAFETY IS TESTED.ANTHONY WITH THE MEDIA COMPANYIN PHILADELPHIA RECEIVED FIRSTINJECTION APRIL 20TH.DO YOU NOTICE ANYTHINGDIFFERENT HOW ARE YOU FEELING.ABSOLUTELY NO SYMPTOMSWHATSOEVER.REPORTER: BLOOD TESTS WILLSHOW IF HE IS DEVELOPINGANTIBODIES TO THE VACCINE,FIRST STEP TO DETERMINE IF ITCAN TRAIN THE IMMUNE SYSTEM TORECOGNIZE AND ATTACK COVID-19.I THINK THAT A VACCINE IS AVIEWINGS THAT EVERYBODY ISLOOKING FOR.I DON'T KNOW FIT IS THEVACCINE THAT WILL BE THESOLUTION.I THINK IT IS IMPORTANT THATWE DO DIFFERENT KINDS OFVACCINE.REPORTER: DOCTOR PABLO ISLEADING THE EVEN PEN TRIAL.IF ALL THIS PANS OUT WHENWOULD THIS BE AVAILABLE.BEGINNING OF THE NEXT YEAREARLIEST.REPORTER: ANTHONY'S HOPING.IT WOULD BE GRATIFYING TOPLAY A REALLY SMALL ROLE, IN,COMING UP WITH A RESPONSE TOPASS THIS PANDEMIC.REPORTER: NOW ANTHONY WHOIS 33 IS A GENERAL PRACTICEPATIENT AT PENN.HE SOUGHT INFORMATION ABOUTTHE TRIAL, IN A REGULARCORRESPONDENCE WITH HIS DOCTORAND QUICKLY SIGNED UP.